MedPath

ASSESSMENT OF DURATION OF POSTOPERATIVE PAIN RELIEF IN PATIENTS RECEIVING ULTRASOUND GUIDED NERVE BLOCK WITH BUPIVACAINE (LOCAL ANAESTHETIC) ALONE OR WITH DEXMEDETOMIDINE (SEDATIVE, ANXIOLYTIC) IN PATIENTS UNDERGOING FEMUR (THIGH BONE) FRACTURE SURGERY

Not Applicable
Completed
Conditions
Health Condition 1: M99-M99- Biomechanical lesions, not elsewhere classifiedHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2021/03/032154
Lead Sponsor
Dr Reshma B M
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1. PATIENTS UNDERGOING ELECTIVE FEMUR FRACTURE SURGERIES.

2. PATIENTS BELONGING TO AMERICAN SOCIETY OF ANAESTHESIOLOGISTS PHYSICAL STATUS (ASA-PS) 1 -3

Exclusion Criteria

1. Patients with history of known allergy to local anaesthetic agent

and/or dexmedetomidine.

2. Pregnancy and lactation.

3. Infection at the block site.

4. Neurological deficit in lower limbs.

5. Impaired cognition / dementia.

6. Multiple injuries requiring pain medications.

7. Substance / opioid abuse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the duration of postoperative analgesia of USG guided <br/ ><br>FICB using bupivacaine alone compared with bupivacaine and <br/ ><br>dexmedetomidine in patients undergoing surgery for fracture femur under <br/ ><br>spinal anaesthesia.Timepoint: Baseline, 15 minutes after performing block, every 2 hours thereafter for 24 hours
Secondary Outcome Measures
NameTimeMethod
1. TO ASSESS TOTAL ANALGESIC REQUIREMENT POSTOPERTIVELY FOR 12-24 HOURS. <br/ ><br>2. PATIENT SATISFACTION SCORE. <br/ ><br>3. TO ASSESS SEDATION LEVELS AND SIDE EFFECTS IF ANYTimepoint: ASSESSMENT FOR 24 HOURS POSTOPERATIVELY
© Copyright 2025. All Rights Reserved by MedPath